🚀 RNAlead is on a mission to conquer Europe!

RNAlead is pleased to announce a new distribution partnership with Tebubio, a leading European supplier of innovative life science solutions.

Through this partnership, researchers, biotech companies, and pharmaceutical organizations across Europe can now access FlashRNA® more easily through Tebu-bio’s established commercial network.

FlashRNA® is a next-generation RNA delivery platform. It combines high delivery efficiency, low immunogenicity, and scalable manufacturing. The technology has already been validated in more than 30 development projects. Moreover, FlashRNA® is a versatile platform designed to address multiple high-value therapeutic areas, including oncology, regenerative medicine, vaccines, and rare diseases.

This partnership marks an important milestone for RNAlead. It strengthens our mission to accelerate the adoption of innovative RNA delivery solutions. As a result, researchers and drug developers can more easily explore alternatives to conventional delivery technologies.

Researchers can now purchase premade FlashRNA® R&D batches directly through Tebubio. This enables rapid technology evaluation and faster proof-of-concept studies.

Beyond these standard products, RNAlead offers customized FlashRNA® solutions. We work closely with our partners to incorporate their own RNA sequences and therapeutic targets. Furthermore, our team provides scientific support throughout the evaluation process.

This combination of immediate access and bespoke development support allows partners to quickly explore the potential of FlashRNA® while benefiting from RNAlead’s expertise to accelerate their RNA therapeutic programs.